Corticosteroid injection into the sacroiliac joint

Evaluation of the effectiveness of of intra-articular sacroiliac injection in patients with sacroiliac pain

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200217046523N4

Enrollment

Registered

2020-10-14

Start date

2020-11-04

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sacroiliac joint pain. Sprain of sacroiliac joint

Interventions

Intervention group: Patients in this group are treated with 10 mg solution of triamcinolone stanoid intra-sacroiliac joint under fluoroscopic guidance using needle # 26. Patients' pain is measured by

Eligibility

Sex/Gender

All

Age

21 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age range 70-21 years Pain in the sacroiliac and lumbar region Pain for more than 6 months Minimum 50% reduction in pain after 30 minutes of intra-articular diagnostic block with 0.5 ml of 2% lidocaine Written consent to enter the study

Exclusion criteria

Exclusion criteria: There are special conditions that are contraindicated for intra-articular injection Existence of diseases such as vertebral disc diseases and vertebral disc herniation Radiculopathy Neuropathy Treatment with anticoagulants

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: At 2, 4 weeks and 6 months after the intervention. Method of measurement: VAS questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Andalib

Esfahan University of Medical Sciences

ali_andelib@yahoo.com+98 31 3337 7986

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026